NCT06405685 2024-05-08Nimotuzumab Plus AG in Pancreatic Cancer With Liver MetastasisTianjin Medical University Cancer Institute and HospitalPhase 2 Unknown30 enrolled
NCT02945267 2016-10-26Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic CancerChinese PLA General HospitalPhase 4 Unknown60 enrolled